Association of Biopsy-proven Nonalcoholic Fatty Liver Disease with Obesity and Apolipoproteins
Apo A1 and B levels and the B/A1 ratio were not associated with histopathological findings in patients with NAFLD. Fibrosis and ApoB1/A were found to be independent risk factors for metabolic associated fatty liver disease. In addition, obesity increases the grade of hepatic steatosis but does not cause lobular inflammation, ballooning or fibrosis.
Authors
- Cafer Ozdemir (ORCID: https://orcid.org/0000-0002-5546-983X)
- Ahmet Uygun (ORCID: https://orcid.org/0000-0001-5203-2627)
- Ömer Kurt (ORCID: https://orcid.org/0000-0001-8045-1036)
- Yıldırım Karslıoğlu (ORCID: https://orcid.org/0000-0003-3748-2085)
- Kadir Öztürk (ORCID: https://orcid.org/0000-0002-2708-3841)
- Türker Türker (ORCID: https://orcid.org/0000-0003-2653-3625)
- Taner Özgürtaş (ORCID: https://orcid.org/0000-0003-1110-6671)
- Hakan Demirci (ORCID: https://orcid.org/0000-0003-1593-1476)
- Ahmet Taş (ORCID: https://orcid.org/0000-0002-1226-5634)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Council of Higher Education (TR)
- Gülhane Askerî Tıp Akademisi (TR)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2024-12-28
- DOI
- https://doi.org/10.15403/jgld-5550
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00